This paper is in the following e-collection/theme issue:

Peer Reviews (266)

Published on in Vol 6 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77627, first published .
Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Authors of this article:

Elena Shkarupeta1 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Laichapis M, Sakulbumrungsil R, Udomaksorn K, Kessomboon N, Nerapusee O, Hongthong C, Poonpolsub S. Authors’ Response to Peer Reviews of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”. JMIRx Med 2025;6:e77623 View